These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34022475)

  • 21. Deep learning-based radiomics predicts response to chemotherapy in colorectal liver metastases.
    Wei J; Cheng J; Gu D; Chai F; Hong N; Wang Y; Tian J
    Med Phys; 2021 Jan; 48(1):513-522. PubMed ID: 33119899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
    Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
    Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control.
    Shady W; Petre EN; Do KG; Gonen M; Yarmohammadi H; Brown KT; Kemeny NE; D'Angelica M; Kingham PT; Solomon SB; Sofocleous CT
    J Vasc Interv Radiol; 2018 Feb; 29(2):268-275.e1. PubMed ID: 29203394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression.
    Kaye EA; Cornelis FH; Petre EN; Tyagi N; Shady W; Shi W; Zhang Z; Solomon SB; Sofocleous CT; Durack JC
    Eur Radiol; 2019 May; 29(5):2698-2705. PubMed ID: 30402706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of pattern classification 24 hours after radiofrequency ablation of liver metastases on CT and positron emission tomography/CT.
    Vandenbroucke F; Vandemeulebroucke J; Ilsen B; Verdries D; Belsack D; Everaert H; Buls N; Ros PR; de Mey J
    J Vasc Interv Radiol; 2014 Aug; 25(8):1240-9. PubMed ID: 24954606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are all local tumour progressions of HCC related to thermal ablation? A study of the causes and classification of local tumour progression.
    Ding WZ; Liu S; Liu F; Cheng Z; Yu X; Han ZY; Yu J; Liang P
    Eur Radiol; 2022 Dec; 32(12):8518-8526. PubMed ID: 35704110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
    Han K; Kim JH; Yang SG; Park SH; Choi HK; Chun SY; Kim PN; Park J; Lee M
    Radiology; 2021 Jan; 298(1):212-218. PubMed ID: 33170105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiomics analysis of baseline computed tomography to predict oncological outcomes in patients treated for resectable colorectal cancer liver metastasis.
    Montagnon E; Cerny M; Hamilton V; Derennes T; Ilinca A; Elforaici MEA; Jabbour G; Rafie E; Wu A; Perdigon Romero F; Cadrin-Chênevert A; Kadoury S; Turcotte S; Tang A
    PLoS One; 2024; 19(9):e0307815. PubMed ID: 39259736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy.
    Ye S; Han Y; Pan X; Niu K; Liao Y; Meng X
    Front Oncol; 2022; 12():843991. PubMed ID: 35692757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the Site of the Primary Affect Outcomes When Ablating Colorectal Liver Metastases with Radiofrequency Ablation?
    Gu Y; Huang Z; Gu H; Gao F; Zhang T; Huang S; Huang J
    Cardiovasc Intervent Radiol; 2018 Jun; 41(6):912-919. PubMed ID: 29582125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase in volume of ablation zones during follow-up is highly suggestive of ablation site recurrence in colorectal liver metastases treated with radiofrequency ablation.
    Kele PG; de Jong KP; van der Jagt EJ
    J Vasc Interv Radiol; 2012 Apr; 23(4):537-44. PubMed ID: 22341635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram.
    Yuan C; Wang Z; Gu D; Tian J; Zhao P; Wei J; Yang X; Hao X; Dong D; He N; Sun Y; Gao W; Feng J
    Cancer Imaging; 2019 Apr; 19(1):21. PubMed ID: 31027510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Comprehensive Machine Learning Benchmark Study for Radiomics-Based Survival Analysis of CT Imaging Data in Patients With Hepatic Metastases of CRC.
    Stüber AT; Coors S; Schachtner B; Weber T; Rügamer D; Bender A; Mittermeier A; Öcal O; Seidensticker M; Ricke J; Bischl B; Ingrisch M
    Invest Radiol; 2023 Dec; 58(12):874-881. PubMed ID: 37504498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation.
    Guo D; Gu D; Wang H; Wei J; Wang Z; Hao X; Ji Q; Cao S; Song Z; Jiang J; Shen Z; Tian J; Zheng H
    Eur J Radiol; 2019 Aug; 117():33-40. PubMed ID: 31307650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The local efficacy and influencing factors of ultrasound-guided percutaneous microwave ablation in colorectal liver metastases: a review of a 4-year experience at a single center.
    Qin S; Liu GJ; Huang M; Huang J; Luo Y; Wen Y; Wang Y; Chen L
    Int J Hyperthermia; 2019; 36(1):36-43. PubMed ID: 30489175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CT-based radiomics for the identification of colorectal cancer liver metastases sensitive to first-line irinotecan-based chemotherapy.
    Qi W; Yang J; Zheng L; Lu Y; Liu R; Ju Y; Niu T; Wang D
    Med Phys; 2023 May; 50(5):2705-2714. PubMed ID: 36841949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can tumor coverage evaluated 24 h post-radiofrequency ablation predict local tumor progression of liver metastases?
    Vandenbroucke F; Vandemeulebroucke J; Buls N; Thoeni RF; de Mey J
    Int J Comput Assist Radiol Surg; 2018 Dec; 13(12):1981-1989. PubMed ID: 29651715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microwave Ablation in the Management of Colorectal Cancer Pulmonary Metastases.
    Kurilova I; Gonzalez-Aguirre A; Beets-Tan RG; Erinjeri J; Petre EN; Gonen M; Bains M; Kemeny NE; Solomon SB; Sofocleous CT
    Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1530-1544. PubMed ID: 29845348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mid-term outcome of positron emission tomography/computed tomography-assisted radiofrequency ablation in primary and secondary liver tumours--a single-centre experience.
    Kuehl H; Stattaus J; Hertel S; Hunold P; Kaiser G; Bockisch A; Forsting M
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):234-40. PubMed ID: 18155453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative margin assessment of radiofrequency ablation of a solitary colorectal hepatic metastasis using MIRADA RTx on CT scans: a feasibility study.
    Sibinga Mulder BG; Hendriks P; Baetens TR; van Erkel AR; van Rijswijk CSP; van der Meer RW; van de Velde CJH; Vahrmeijer AL; Mieog JSD; Burgmans MC
    BMC Med Imaging; 2019 Aug; 19(1):71. PubMed ID: 31429708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.